Live Breaking News & Updates on Monitoring Test|Page 2

Stay updated with breaking news from Monitoring test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A CT scan for COVID merits a word of caution


A CT scan for COVID merits a word of caution
Updated:
Updated:
May 06, 2021 01:48 IST
Going by data and the risk factors, its widespread use in diagnosing the infectious disease needs to be questioned
Share Article
AAA
Going by data and the risk factors, its widespread use in diagnosing the infectious disease needs to be questioned
There are broadly three reasons why we perform tests in clinical medicine: diagnosis (what is the disease?), etiognosis (what caused a disease?), and prognosis (how will the disease evolve?). It is also important that the outcome of a test should guide treatment in some way, especially when it is being touted as being a monitoring test that provides unique information that cannot be obtained by easier means. Considering how widespread the use of computerised tomography (CT) scans of the thorax during the novel coronavirus pandemic has been, one would assume that the test would satisfy one, if not all the above criteria, f ....

United States , Pd Hinduja National Hospital , Research Centre , Cochrane Collaboration , New England Journal , Consultant Respirologist , National Hospital , Medical Research Centre , Lancelot Pinto , Clinical Medicine , Outcome Ofa Test , Monitoring Test , Use Of Computerised Tomography , Ct Scans , Novel Coronavirus Pandemic , Accurate Diagnostic Test , Accuracy Of Ct Scans In Diagnosing Covid 19 , Positive Rt Pcr , Overworked Laboratory Services , Accurate Test For Etiognosis , Ct Pattern , Severity Of Lung Involvement , The New England Journal Of Medicine , Risk Of Transmission The Virus , Possibility Of Other Lung Diseases , Blood Clots In The Lungs ,

Asia Pacific HIV Diagnostics Market To Worth Over US$ 840 Million with 12.3% CAGR up to 2026


Search jobs
05-Feb-2021
Asia Pacific HIV Diagnostics Market To Worth Over US$ 840 Million with 12.3% CAGR up to 2026
, by Product Type (Instruments and Reagents & Kits), by Test Type (Screening (Third Generation and Fourth Generation), Differentiation & Confirmation Test, and Monitoring Test (CD4 Tests and Viral Load Tests)), By End User (Hospitals and Clinics, Diagnostic Laboratories, Home Care Settings, and Others), and by Country (China, Japan, South Korea, ASEAN, India, Australia, and Rest of Asia Pacific) was valued at 
US$ 301.1 million in 2017, and is projected to exhibit a CAGR of 12.3
% during the forecast period  (2018 – 2026), 
as highlighted in a new report published by Coherent Market Insights. ....

United States , United Kingdom , South Korea , Asia Pacific , Lytical Laboratories Inc , Medmira Inc , Bio Rad Laboratories Inc , United Nations Program , Health Sciences Authority , Merck Kga , Merck Kgaa , View Press , Abbott Laboratories , Un Sustainable Development Goal , Siemens Healthineers Inc , Danaher Corporation , Product Type , Test Type , Third Generation , Fourth Generation , Confirmation Test , Monitoring Test , Viral Load Tests , End User , Diagnostic Laboratories , Home Care Settings ,